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1. Introduction
1.1. Parkinson’s disease (PD)
Parkinson’s disease is a progressive neurodegenerative disease that affects 1 % of people over
60 years of age [9]. In PD, there is a dopaminergic neuronal loss in the substantia nigra in the
basal ganglia of the cerebra [48]. It has been observed that the basal ganglia has a specific effect
on the temporal organization of motor cortical activity during muscle contractions. In this
way, the dysfunction of the basal gangliamay lead tomotor symptoms of PD. [37] The primary
symptoms of PD include tremor, muscle rigidity and slowness of movements. The diagnosis
is based on the presence of the primary symptoms and on the response to medication. [17,
18]. However, the diagnosis can be problematic. Clinicopathological studies from the UK
and Canada have shown that the disease is diagnosed incorrectly in about 25 % of patients
[48]. The pre-motor period before diagnosis may be long (5–20 years) and at the time of the
diagnosis already 50–60 % of the dopaminergic neurons may be lost [22, 38].
Although there is no cure for PD, the symptoms can be relieved reasonably with medication
or with the deep brain stimulation (DBS) [17]. The motor impairment, the disease progression
and the efficacy of treatment are commonly evaluated subjectively using standardized rating
scales such as the Unified Parkinson’s disease rating scale (UPDRS) [12, 15]. No objectively
measured characteristics and methods are widely used for quantifying motor symptoms of
PD [2].
Several objective methods have been proposed for improving the diagnostic accuracy of PD,
for enabling earlier diagnosis, and for quantifying the disease severity, progression and the
efficacy of treatment. These methods include: kinematic measurements of motor tasks (e.g.
finger tapping), testing of olfactory loss, imaging techniques (e.g. magnetic resonance imaging
and positron emission tomography), and biochemical tests of blood and cerebrospinal fluid.
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However, none of the proposed methods is widely used for PD. The validation of new
methods for clinical use takes time. In order to be more sensitive than the traditional methods
it is probable that a combination of several methods will be needed for PD. [2, 11, 24]
1.2. Surface electromyography and kinematic measurements in PD
Surface electromyography (EMG) and kinematic measurements are non-invasive and
relatively simple and cost-effective methods for quantifying neuromuscular function and
movement. Therefore, these methods may be suitable for quantifying objectively the motor
impairment in PD and the effects of treatment. A few new technologies based on kinematic
sensors have been recently commercialized for measuring motor symptoms of PD. The
kinematic measurements provide information about human movements. However, it is
possible that surface EMG provides earlier or more direct information about PD than the sole
kinematic measures based on movement.
Several studies have analyzed the surface EMG and kinematic signals of PD patients in
comparison to the signals of healthy subjects and aimed to correlate the most significant
findings with the clinical rating scales. Differences between patients and healthy subjects
have been observed in the tremor-EMG coherence [50], in the cortico-muscular coherence
[37] and in the muscle activation patterns during limb movements [13, 26, 35]. In the gait
characteristics, differences have been observed in the gait speed and stride length, in the arm
and leg swing and in the muscle activation patterns of gait [5–7, 36, 43].
Several studies have evaluated effects of PD treatment (medication and DBS) on the basis of
EMG and kinematic measurements. It has been observed that the medication and DBS may
modify the tremor amplitude, regularity and frequency [4, 41, 42], movement speed [3, 8, 34,
40, 44, 49, 51, 52], joint kinetics and muscle activation during movements [55], EMG burst
patterns during movement [34, 51, 52] and the cortico-muscular coherence [25, 37]. There
is currently a lot of interest for characterizing EMG and kinematic signals of PD patients.
However, many studies have analyzed the EMG signals of PD patients by using conventional
amplitude- and spectral based methods. More information about PD could be extracted from
the EMG signals by using also more modern methods of signal analysis, by analyzing sets of
signal features and by analyzing the signal characteristics also on individual level.
EMG signals are impulse-like waveforms because they consist of motor unit (MU) action
potentials. The level of MU synchronization is increased in PD [14, 50], which appears
as an increased number of recurring spikes and bursts in the EMG signals. Therefore,
there is important information about PD in the morphology of the EMG signal and in the
recurring signal patterns. It has been observed that the conventional EMG signal parameters
(amplitudes and the mean and median frequencies) are not effective in capturing impulse-like
structures [23]. Therefore, more modern methods of signal analysis are needed for analyzing
the EMG signals of PD patients.
1.3. Our approach for studying surface EMG and kinematic measurements in PD
In order to extract PD-related information from the surface EMG signals effectively, we
proposed specific methods based on signal morphology, nonlinear dynamics and wavelets for
analyzing the EMG signals of PD patients in [28–32]. One aim of those studies was to develop
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objective methods for discriminating between PD patients and healthy subjects on the basis of
surface EMG signal morphology [32] and on the basis of simultaneous EMG and acceleration
(ACC) recordings during isometric [28] and dynamic muscle contractions [29]. Another aim
was to develop methods based on surface EMG and kinematic measurements and analysis
for quantifying effects of PD treatment (medication and DBS) on individual level. All of those
studies presented an innovative approach, that combines a principal component (PC) -based
method with a set of effective signal features, for analyzing the EMG and acceleration signals
in PD. In the following sections 2, 3 and 4, we describe the methods that were developed and
used for feature extraction and discrimination between subjects in [28–32]. All methods were
tested with the measured data. In total, the measurement data from 62 PD patients and 72
healthy subjects were analyzed. The main findings of those studies are also described.
2. Analysis EMG signal morphology in PD
EMG signal is a sum of MU action potentials at a given location and therefore it is an
impulse-likewaveform. The EMG signals of PD patients are characterized by recurring spikes
and bursts (see Figure 1) that are likely caused by the increased level of MU synchronization.
Important information about PD is in the EMG signal morphology and in the recurring signal
patters.
In [32], the EMG signal morphology of 25 PD patients and 22 healthy subjects was analyzed by
using sample histograms and crossing rate (CR) expansions. The analyzed EMG signals were
measured during the isometric contraction of biceps brachii (BB) muscles. During the task,
subjects were asked to hold their elbows at a 90° angle with their palms up. Themeasurements
were performed by using the ME6000 -biosignal monitor (Mega Electronics Ltd., Kuopio,
Finland) and disposableAg/AgCl electrodes (Medicotest, modelM-00-S, Ølstykke, Denmark)
in bipolar connection. The sampling rate was 1000 Hz.
Typical EMG signals of one healthy subject and one PD patient are presented in Figure 1. One
can observe that the EMG signal of the patient contains recurring EMG bursts while the EMG
signal of the healthy subject does not.
2.1. Feature extraction by using sample histograms and CR expansions
Sample histograms were extracted from the scaled (between -1 and 1) EMG signals with
200 bins and the CR expansions from the scaled EMGs as the number of crossings at given
threshold levels (201 threshold levels). An example of the sample histogram and the CR
expansion for the healthy subject and for the PD patient are presented in Figure 1. One can
observe that the sample histogram of the patient is sharper and the CR expansion narrower
than those of the healthy subject.
2.2. Discrimination analysis between subjects
The calculated sample histograms and CR expansions of PD patients (withmedication on) and
healthy subjects were used as high-dimensional feature vectors for discrimination analysis
between subjects. The PC-based approach was used for decreasing the dimensionality of the
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Figure 1. EMG signals of one healthy subject (top) and one PD patient (bottom). The sample histograms
and crossing rate expansions of the healthy subject and the PD patient.
feature vectors and the discriminant analysis of subjects was performed in a two-dimensional
feature space.
In the PC-based approach [19], each feature vector zj ∈ RNp is modeled with a linear model
zj = Hθj + vj. (1)
In the linear model, H = [φ1 φ2 . . . φK ] ∈ RNp×K is the model matrix that contains the basis
vectors φk ∈ RNp in its columns. Vector θj ∈ RK contains the model weights and vj ∈ RNp the
model error for the j’th feature vector. The basis vectors φk are selected to be the eigenvectors
of the data correlation matrix
Rz =
1
M
M
∑
j=1
zjz
T
j , (2)
where M is the total number of feature vectors and (·)T denotes the transpose. Because the
eigenvectors are orthonormal, the least squares solution for themodel weights θj is of the form
θˆj = (H
TH)−1HTzj = HTzj. (3)
These weights are called the principal components. By choosing K (K < Np) eigenvectors
corresponding to K largest eigenvalues for modeling, the best K-dimensional orthogonal
approximation for the data set is obtained. The PCs are the new uncorrelated features and
they can be used for discriminating between subjects in a low-dimensional feature space.
In [32], three feature vectors were formed for each subject: one containing the EMG sample
histogram, one containing the CR expansion and one containing both of them (augmented
PC approach). Thus, the original dimensionality of the feature vectors was reasonably high
(Np ≥ 200). The feature vectors of one PD patient and one healthy subject in the augmented
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PC approach are illustrated in Figure 2. In addition, the correlation matrix and the three
eigenvectors corresponding to the three largest eigenvalues are presented in the same figure.
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Figure 2. The feature vectors of one PD patient (black) and one healthy subject (gray) in the augmented
PC approach (top left). Three eigenvectors corresponding to the three largest eigenvalues (left). The data
correlation matrix (top right). The third PCs θj(3) with respect to the first PCs θj(1) of 22 healthy subjects
(+) and 25 PD patients (◦) (bottom right).
The correlation matrix in Figure 2 contains four white areas with high correlation. The white
area in the top left corner describes correlations between the CR expansion values. The white
area in the bottom right corner describes correlations between the sample histogram values.
The non-diagonal white areas describe cross-correlations between the CR expansion values
and the sample histogram values.
The eigenvectors in Figure 2 can be interpreted as follows:
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• The first eigenvector is the best mean-square fit for the feature vectors of all subjects.
Thus, it is similar to the mean of all feature vectors. Therefore, the first PC describes the
amplitude of the histogram and the CR expansion with respect to the mean of all subjects.
• The second eigenvector is the best mean-square fit for the residual of the first fit. The
second eigenvector describes variations in the peaks (modes) of the histograms and CR
expansions of all subjects.
• The third eigenvector models variations in the heights and widths of the histograms and
CR expansions in the whole data set.
The rest of the eigenvectors contain information about higher frequencies of the data and do
not interest us in this case. The biggest differences between patients and healthy subjects
were found in the third PC and some differences were observed in the first PC. Therefore, the
discrimination between subjects was performed with respect to the third and the first PC.
2.3. Results
A linear discriminant was used in [32] for discriminating between the subjects in the
two-dimensional feature space that was spanned by the third and the first PCs. The best
discrimination results were obtained by using the augmented PC approach (see results in
Figure 2). According to the results, 72 % of PD patients can be discriminated from 86 % of
healthy subjects on the basis of EMG signal morphology.
3. Analysis of simultaneous EMG and acceleration recordings in PD
3.1. EMG and acceleration measurements
We analyzed simultaneous EMG and acceleration measurements of PD patients and healthy
subjects in [28, 29] and aimed to develop methods for discriminating between the patients
and the healthy subjects on the basis of the measured signals. The signals were measured
during isometric contraction of BB muscles [28] and during dynamic elbow flexion-extension
movements [29].
During the isometric task, the subjects were asked to hold their elbows at a 90° angle with their
palms up. During the dynamic task, the subjects were asked to flex and extend their both
elbows vertically and freely in two-second cycles with their palms up. Surface EMGs were
registered continuously from the BBmuscles and the accelerations of forearms simultaneously
from the palmar side of subject’s wrists. All measurements were performed by using the
ME6000 -biosignal monitor (Mega Electronics Ltd., Kuopio, Finland), disposable Ag/AgCl
electrodes (Medicotest, model M-00-S, Ølstykke, Denmark) in bipolar connection and tri-axial
accelerometers (Meac-x, Mega Electronics Ltd., range ±10 g). Signals were sampled with the
rate of 1000 Hz. The resultant of the acceleration was used in the analysis. Low-frequency
trends were removed from both signals by using the smoothness priors method [46]. The
high-pass cut-off frequencies were 10 Hz for EMG and 2 Hz for acceleration.
Typical EMG and acceleration signals of one PD patient and one healthy subject during
the isometric and dynamic task are presented in Figure 3. It is observed in the isometric
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Figure 3. EMG and acceleration recordings of one PD patient (left) and one healthy subject (right)
during the isometric and the dynamic task.
recording, that the EMG signal of the PD patient differs from the EMG signal of the healthy
subject by containing recurring EMG bursts and the acceleration signal by containing regular
high-amplitude oscillation. This oscillation is likely due to the resting and postural tremor. It
is observed in the dynamic recording, that the EMG signal of the PD patient is characterized
by recurring spikes and the acceleration recording by containing high-amplitude oscillation
during the extension phases of the movement. The oscillation in the acceleration signal (which
was high-pass-filtered with 2 Hz as cut-off frequency) is likely due to muscle rigidity and
kinetic tremor (tremor that occurs during movement). In the flexion phases of the movement,
the differences between the patient and the healthy subject are not as pronounced.
3.2. Feature extraction from EMG and acceleration signals
It was observed in [23] and [28, 29] that the conventional amplitude- and spectral-based EMG
parameters (root mean square value and median frequency) are not effective in characterizing
the EMG signals of PD patients in comparison to the signals of the healthy subjects. Therefore,
we extracted a set of other PD characteristic signal features from the isometric [28] and
dynamic EMG and acceleration recordings [29]. These parameters are detailed in Table 1 and
they were calculated as epoch averages from the isometric EMG and acceleration signals and
as time-varying from the dynamic signals.
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Task type Signal features Notations
Isometric sample kurtosis of EMG kr and kl
crossing rate variable of EMG crr and crl
correlation dimension of EMG D2,r and D2,l
recurrence rate of EMG %RECr and %RECl
sample entropy of ACC SampEnr and SampEnl
coherence between EMG and ACC Cohr and Cohl
Dynamic recurrence rate of EMG %RECr and %RECl
cross-recurrence rate of EMG %RECr,l
wavelet variable of EMG Wmax,r andWmax,l
cross-wavelet variable of EMG Wmax,rl
power of ACC Pacc,r and Pacc,l
sample entropy of ACC SampEnr and SampEnl
Table 1. PD characteristic signal features and their notations. The subscripts r and l in the notations
stand for the side of the body.
3.2.1. Parameters of surface EMG signal morphology
In [28], we used two parameters (k and cr) for measuring the peakedness of EMG signals. The
sample kurtosis was calculated as the fourth centered moment of the time series x (length N):
k =
1
N ∑
N
i=1 (xi − μx)4
σ4x
, (4)
where μx is the mean and σx the standard deviation (SD) of the sample values. Parameter k is
higher for more peaked signals.
The parameter cr was calculated as the width/height of the CR expansion. The width of the
CR expansion was defined at the level of 50 crossings/second and the height as the maximum
value of the CR expansion. Parameter cr is lower for more peaked signals.
3.2.2. EMG parameters of nonlinear dynamics
In [28, 29], we used parameters of nonlinear dynamics (correlation dimension, recurrence
rate and cross-recurrence rate) for analyzing the EMG signal complexity and recurring EMG
patterns. In nonlinear dynamics, the original time series (EMG signal) x is used to form
embedding vectors ui
ui = [xi xi+λ xi+2λ . . . xi+(m−1)λ], (5)
where λ is the delay parameter andm the embedding dimension [45]. The number of different
embedding vectors is Nm = Ne − (m− 1)λ for each epoch (length Ne) of the time series x.
The correlation dimension [16] describes the complexity of the time series and it can be
calculated from the embedding vectors as follows. First, the Euclidean distances between
each pair of embedding vectors ui and uj in (5) are quantified as
de(ui, uj) =
√√√√m−1∑
k=0
|xi+kλ − xj+kλ|2. (6)
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The correlation sum is then calculated as
Cm(r) =
1
N2m
Nm
∑
i,j=1
Θ(r− de(ui, uj)) (7)
Θ(s) =
{
0, s < 0
1, s ≥ 0,
where r is the threshold distance. The correlation dimension is formally defined as
D2(m) = lim
r→0
lim
Nm→∞
logCm(r)
log r
. (8)
Practically, D2 is calculated as the slope of the regression curve in the log-log-representation.
Recurrence rate [53] measures the percentage of recurring patterns in the EMG signal. It can
be calculated from the embedding vector distances in (6) as a percentage of distances that are
below of the threshold distance r. The binary image, that contains a value 1 in the cells (i, j)
where de(ui, uj) < r, is called the recurrence plot. The recurrence plots of one healthy subject
and one PD patient are illustrated in Figure 4. One can observe that the recurrence plot of the
patient contains more cells with the value 1 (white cells) than the recurrence plot of the healthy
subject. It means that the EMG signal of the patient contains more recurring patterns than the
EMG signal of the healthy subject. In the cross-recurrence rate, the embedding vectors in (5)
are formed for two time series and the Euclidean distances in (6) are evaluated between the
embedding vectors of the two different time series.
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Figure 4. EMG signals and recurrence plots of one healthy subject and one PD patient.
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3.2.3. Spectral-based parameters
In spectral analysis, the aim is to present the signal in the frequency-domain by estimating
its power spectral density (PSD). The PSD estimation can be based on a Fourier transform
or wavelet transform or on parametric modeling. In [28, 29], the Fourier- and wavelet-based
approaches were used for analyzing the EMG and acceleration signals of PD patients and
healthy subjects.
The coherence was used in [28] for quantifying similarities in the power spectra of the EMG
and acceleration signals. It was calculated from the PSDs of the EMG and acceleration signals
(Px( f ) and Py( f )) and from the cross-spectral density Pxy( f ), which were estimated by using
the Welch’s averaged periodogrammethod [54]. The magnitude-squared coherence is defined
as
Cxy( f ) =
|Pxy( f )|2
Px( f )Py( f )
(9)
and it gives values between 0 and 1. Variable Coh was calculated as the area of the coherence
spectrum above a threshold value in the frequency range 0–50 Hz. The magnitude-squared
coherence estimates of one healthy subject and one PD patient are presented in Figure 5. One
can observe that the area of the coherence spectrum is larger for the PD patient than for the
healthy subject.
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Figure 5. EMG and acceleration signals and magnitude-squared coherence estimates of one healthy
subject and one PD patient.
While in Fourier approach the basis functions in the spectral decomposition are global
functions, in wavelet approach [1] the functions are local. Therefore, the wavelet-based
methods can be more effective than the Fourier-based method in detecting time varying
features in the spectrum [10]. The basic idea in the wavelet transform is to decompose the
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signal into a set of basis functions, which are obtained by scaling and shifting the wavelet
function ψ(t). In continuous form, the wavelet transform of the signal x(t) is defined as
Wx(a, b) =
1√
a
∫ ∞
−∞
x(t)ψ∗
(
t− b
a
)
dt, (10)
where a is the scale, b is the shift, and (·)∗ denotes the complex conjugate operator. Different
kinds of wavelet functions have been defined for analysis. For discrete signals one must use
discrete wavelets. The magnitude-squared wavelet transform is called the scalogram
PWx (a, b) = |Wx(a, b)W∗x (a, b)|. (11)
If the wavelet transforms of two signals x and y are denoted with Wx(a, b) and Wy(a, b), the
wavelet cross-scalogram is defined as
PWxy(a, b) = |Wx(a, b)W∗y (a, b)|. (12)
In [29], the discrete Morlet wavelet was used for analysis as in many other EMG studies
[10, 20, 40]. The scalograms (11) were calculated from the EMG signals of both sides of the
body and the cross-scalogram (12) between the right and left side signals. The scalograms
and cross-scalograms were scaled to present the percentage of energy for each wavelet
coefficient as a function of time. The wavelet parameterWmax was calculated as the maximum
energy of all wavelet coefficients from both the scalograms and the cross-scalograms as a
function of time. The wavelet cross-scalograms and parameters Wmax,rl are presented for
one healthy subject and one PD patient in Figure 6. One can observe that in the wavelet
cross-scalogram of the patient the energy is more spread into different wavelet coefficients
than in the cross-scalogram of the healthy subject. Parameter Wmax,rl is lower for the patient.
3.2.4. Acceleration signal features
Sample entropy is a parameter of nonlinear dynamics and it can be used for quantifying
the regularity of acceleration signals in PD when compared to the healthy subjects. It was
calculated in [28, 29] from the embedding vectors in (5) as described in [27]. In [29], the
power of the acceleration signal was extracted from the dynamic acceleration recordings for
quantifying kinetic tremor and rigidity during movement.
3.3. Cluster analysis of subjects
The aim in [28, 29] was to develop a method for discriminating between PD patients and
healthy subjects on the basis of EMG and accelerations signal features. In total, the data from
42 PD patients and 59 healthy subjects were analyzed in [28] and the data from 49 PD patients
and 59 healthy subjects were analyzed in [29].
In [28, 29], there were many parameters that could capture essential information in the
measured signals. These original signal features pj (j = 1, 2, ...,Np) (detailed in Table 1) were
used to form feature vectors zj ∈ RNp for each subject.
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Figure 6. Right and left side EMG signals of one healthy subject and one PD patient. Wavelet
cross-scalograms andWmax,rl parameters for the healthy subject and the PD patient.
zj = [p1 p2 . . . pNp ]
T (13)
The PC-based approach [19] was used in both studies for reducing the number signal
features and for transforming the original possibly correlated parameters into uncorrelated
parameters.
In [28], one feature vector was formed for each healthy subject, for each patient with
medication on (MED on) and for 13 patients also with medication off (MED off, no medication
24 hours before the measurement) by using the twelve EMG and acceleration parameters (six
parameters from each body side) that are detailed in Table 1. The original signal parameters
were normalized (to zero mean and unit SD of all subjects) before applying the PC approach.
The PC approach was applied once as described in section 2.2. In [29], two feature vectors
were formed for each patient and for each healthy subject of the ten EMG and acceleration
parameters that are detailed in Table 1. One of the feature vectors was formed by using the
mean parameter values during flexion and the other by using the mean parameter values
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during extension. The signal variables were normalized and the PC approach was applied
separately for the flexion and extension phases of the movement as described in section 2.2.
Cluster analysis was used in [28, 29] for grouping subjects with similar EMG and acceleration
signal features into groups. This could be done by clustering the model weights (PCs) in the
sum (1). An iterative k-means algorithm [47] was used for clustering the feature vectors of
subjects in a two-dimensional feature space. In k-means algorithm, the only parameter given
to the algorithm is the number of clusters. The algorithm begins by choosing initial estimates
for each cluster center point. In each iteration step, it is determined to which cluster the feature
vectors belong. The feature vector belongs to that cluster for which the squared Euclidean
distance between the vector and the cluster center point in the two-dimensional feature space
is minimized. The cluster center points are updated to be the mean of the feature vectors in
each cluster in the two-dimensional feature space. The iteration continues until the sum of
vector-to-center point distances summed over all clusters is minimized.
The validation of the clustering results was performed by using the leave-one-out method.
In the method, the eigenvectors and PCs are solved for each combination of M − 1 feature
vectors, where M means the total number of feature vectors. That is, one feature vector is
left out of the group each time the eigenvectors and PCs are computed. The clustering is
then performed for each combination of M − 1 feature vectors, and in each case, it is tested
to which cluster the feature vector that was left out belongs. In [28, 29], the correct ratings of
clustering were defined as the percentage (mean±SD values) of healthy subjects that belong
to the healthy subject cluster and the percentage of patients that belong to the patient clusters.
3.4. Discrimination results
In [28], twelve features were extracted from the isometric EMG and acceleration signals of 59
healthy subjects and 42 PD patients. The normalized signal features (mean±SD values) for
the healthy subject group and for the PD patient group are presented in Figure 7. The results
show that the parameters SampEn, cr and D2 seem to be lower and the parameters k, Coh and
%REC higher for the patients than for the healthy subjects. That is, the EMGs of the patients
tend to be less complex and contain more recurring patterns than the EMGs of the healthy
subjects. The acceleration signals of the patients tend to be more regular and more coherent
with the EMGs than the acceleration signals of the healthy subjects.
The cluster analysis of subjects was performed in a two-dimensional feature space, that was
spanned by the PC sum θj(2) + θj(5) and the first PC θj(1) by using the k-means algorithm.
This PC sum was used, because it works better in discrimination than the single PCs. The
results in Figure 7 show that 90 % of the healthy subjects belong to the cluster O1 and 76 %
of the patients in two other clusters O2 and O3. Seven patients with severe motor symptoms
are distinguished in O3. The ten patients in the healthy subject cluster O1 have only little or
no tremor at all in their hands. The validation by using the leave-one-out method resulted in
correct discrimination rates of 90 ± 1 % for the healthy subjects and 74 ± 6 % for the patients.
In [29], ten features were extracted from the EMG and acceleration signals of 59 healthy
subjects and 49 PD patients and used to form feature vectors for subjects. The normalized
signal features (mean±SD values) for the healthy subject group and for the PD patient group
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Figure 7. Mean ± SD values of normalized signal features for the patient group (◦) and for the healthy
subject group (+) (left). The cluster analysis of 42 PD patients (◦) and 59 healthy subjects (+) in the
feature space (θj(2)+θj(5) with respect to θj(1)). The three clusters O1, O2 and O3.
in flexion and in extension are presented in Figure 8. The results show that parameters %REC
and Pacc tend to be higher and parameters SampEn and Wmax lower for patients than for
healthy subjects both in flexion and in extension. That is, the EMGs of the patients tend to
contain more recurring patterns than the EMGs of the healthy subjects and the EMG wavelet
power tends to be more spread for patients. The acceleration signals of the patients tend to be
of higher amplitude and more regular than the acceleration signals of the healthy subjects.
The cluster analysis of subjects was performed in a two-dimensional feature space that was
spanned by the second PC and the first PC by using the k-means algorithm. The results are
presented in Figure 8. According to the results, the method can discriminate 80 ± 1 % of the
patient extension movements from 87 ± 1 % of the extension movements of healthy subjects,
and 73 ± 1 % of the patient flexion movements from 82 ± 1 % of the flexion movements of
healthy subjects. The leave-one-out method was used for validation. The patients, that could
not be discriminated from the healthy subjects, had mild motor symptoms of PD.
4. PC-based approaches for quantifying effects of treatment
In addition to the discrimination analysis between subjects, the principal component -based
approach can be used for quantifying the effects of treatment. In [30, 31], we aimed to develop
objective methods for quantifying effects of PD treatment (DBS and medication) on the basis
of surface EMG and acceleration measurements and analysis.
4.1. EMG and acceleration measurements for quantifying effects of treatment
In [30], the PC-based approach was used for quantifying the effects of DBS treatment on the
basis of a set of EMG and acceleration signal features. In total, the measurement data from 13
PD patients with DBS and 13 healthy subjects were analyzed. Measurements were performed
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Figure 8. Mean ± SD values of normalized signal features for the patient group (◦) and for the healthy
subject group (+) in flexion and in extension (top). The cluster analysis of 49 PD patients (◦) and 59
healthy subjects (+) in the feature space (θj(2)with respect to θj(1)).
during the isometric contraction of BBmuscles (see section 3.1) and they were performed once
for the healthy subjects and twice for the patients: with DBS on (stimulator was turned on) and
with DBS off (stimulator was turned off). Ninth order Butterworth low-pass filter with 110 Hz
cutoff was used for removing the DBS artifact from the EMG signals. The low-pass filtering
was performed similarly for all subjects (patients and healthy subjects). The UPDRS -motor
examination was performed for each patient with DBS on and with DBS off. The measured
signals of one PD patient with DBS on and off are presented in Figure 9. One can observe
that the EMG signal of the patient contains recurring EMG bursts and the acceleration signal
high-amplitude tremor with DBS off but not with DBS on.
In [31], the PC-based approach was used for quantifying the effects of anti-parkinsonian
medication on the basis of a set of EMG and acceleration signal features. In total, the
measurement data from nine PD patients were analyzed. The subjects were measured in four
differentmedication conditions: off-medication, and two and three and four hours after taking
themedication. The isometric task (described in section 3.1) was analyzed. TheUPDRS -motor
examination was performed for each patient in each medication condition. The EMG and
acceleration signals of one PD patient in each medication condition are presented in Figure
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Figure 9. The EMG and acceleration signals of one PD patient with DBS on and with DBS off.
10. It is observed that the number of recurring EMG bursts and the amplitude of tremor
decrease with medication and start to increase three hours after taking the medication.
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4.2. EMG and acceleration signal features for characterizing effects of treatment
Several EMG and acceleration signal features were observed to be effective in characterizing
the effects of treatment on PD patients in [30, 31]. These features are detailed in Table 2.
Treatment Signal features Notations
DBS correlation dimension of EMG D2,r and D2,l
recurrence rate of EMG %RECr and %RECl
root mean square amplitude of ACC RMSr and RMSl
sample entropy of ACC SampEnr and SampEnl
coherence between EMG and ACC Cohr and Cohl
Medication sample kurtosis of EMG kr and kl
recurrence rate of EMG %RECr and %RECl
root mean square amplitude of ACC RMSr and RMSl
sample entropy of ACC SampEnr and SampEnl
Table 2. PD characteristic signal features for quantifying effects of treatment. The subscripts r and l in
the notations stand for the side of the body.
The parameters were calculated as described in section 3.2. The root mean square amplitude
of acceleration was calculated for quantifying tremor amplitude.
4.3. Principal components in quantifying the effects of treatment
In [30], the ten signal features (five features from each body side) in Table 2 were normalized
(to zero mean and unit SD of healthy subjects) and used to form feature vectors for subjects.
One feature vector was formed for each healthy subject and two feature vectors for each
patient: one with DBS on and one with DBS off. The PC approach (see section 2.2) was applied
once. The eigenvectors were solved by using the feature vectors of healthy subjects. In this
way, the healthy subject group formed the normal group for later comparison.
In [31], the eight signal parameters in Table 2 were normalized (to zero mean and unit SD
of all patients) and used to form feature vectors for PD patients. Four feature vectors were
formed for each patient (one feature vector in each medication condition). The PC approach
(see section 2.2) was applied once.
4.4. Results
In [30], the group mean values of the parameters D2 and SampEn increased and the group
mean values of the parameters %REC, RMS and Coh decreased with DBS for the patient
group. However, the SDs of the parameters were very high for the patient group because
of its heterogeneity. Therefore, the patient measurements were studied individually. The
first and the third PCs worked best in characterizing effects of DBS and differences between
patients and healthy subjects. According to the results in Figure 11, 12 out of 13 patients
are closer to the center point of healthy subjects with DBS on than with DBS off in the
two-dimensional feature space (θ3(j)with respect to θ1(j)). That is, the EMG and acceleration
signals of PD patients are more similar with the signals of the healthy subjects with DBS on
than with DBS off. The distances of the patients from the center of healthy subjects and the
clinical UPDRS -motor scores are highly individual (see Table 3). It was observed in a more
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detailed analysis that the method is most sensitive to PD with associated tremor. In Figure
11, one patient is farther from the healthy subjects with DBS on than with DBS off. This
patient has higher tremor (acceleration signal) amplitude and regularity and less complex
EMG recordings (higher %RECand lowerD2) with DBS on than with DBS off. For that patient,
the measurement results contradict the subjective clinical scores.
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Figure 11. The third PCs θj(3) with respect to the first PCs θj(1) of 13 healthy subjects (+) and 13 PD
patients with DBS on (◦) and off (). The patients are divided into two figures, but the healthy subjects
are the same in both figures. The DBS on- and off-states of each patient are connected with a line.
In [31], the first PC worked best in characterizing the effects of medication. The first PCs and
the total UPDRS -motor scores in each medication condition for each patient are presented in
Figure 12. One can observe that the total UPDRS -motor scores decrease (motor symptoms
are relieved) with medication for all patients. Correspondingly the first PCs decrease with
medication for eight out of nine patients. By examining the first eigenvector in Figure 12 one
can realize that the reduction in the first PC indicates reduction in the parameters k (less spiky
EMG), %REC (less recurring patterns) and RMS (lower tremor amplitude), and increase in the
parameter SampEn (more complex tremor). The severity of motor symptoms (UPDRS -motor
score) starts to increase 2–3 hours after medication for all patients, which indicates that the
efficacy of medication starts to weaken 2–3 hours after medication. Correspondingly, the first
PCs start to increase 2–3 hours after medication for seven out of nine patients. The UPDRS
-motor scores and the first PCs do not start to increase at the same time for all patients, which
indicates that these scores do not measure exactly the same thing.
5. Discussion
There is a need for finding objective methods for Parkinson’s disease for improving the
diagnostic accuracy, for enabling earlier diagnosis, and for quantifying the disease progression
and the efficacy of treatment [2, 11, 24]. Surface EMG and the kinematic measurements may
be potentially useful methods for quantifying the motor impairment in PD and the effects of
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Patient no. UPDRS off UPDRS on Distance off Distance on
1 56 43 26 25
2 64 48 32 12
3 59 40 7 5
4 34 14 180 30
5 71 42 289 4
6 38 31 5 12
7 47 28 6 2
8 57 33 6 4
9 43 34 13 11
10 43 24 11 10
11 44 30 6 5
12 62 38 5 4
13 43 30 5 3
Table 3. Total UPDRS -motor scores and the distances from the center of healthy subjects with DBS on
and off.
treatment. However, the EMG signals of PD patients are characterized by spikes and bursts
that are not effectively captured with conventional amplitude- and spectral-based parameters
of EMG. Therefore, more novel methods of EMG analysis are needed for PD.
5.1. Discrimination between patients and healthy subjects
We have developed methods for discriminating between PD patients and healthy subjects
on the basis of surface EMG and kinematic measurements and analysis in [28, 29, 32].
One developed approach was based on analyzing the surface EMG signal morphology
[32]. One approach was based on analyzing isometric [28] and one approach on analyzing
dynamic muscle contractions [29]. Principal components were used in each approach for
discrimination between subjects. All methods were tested with the measured data. The
obtained discrimination rates were 72 % for patients and 86 % for healthy subjects on the basis
of surface EMG signalmorphology, 76 % for patients and 90 % for healthy subjects on the basis
of isometric EMG and acceleration recordings, 73 % for patients and 82 % for healthy subjects
on the basis of elbow flexion movements, and 80 % for patients and 87 % for healthy subjects
on the basis of elbow extension movements. These percentages predict the sensitivities and
specificities of the methods in the subject groups that were studied.
The best discrimination rates between patients and healthy subjects were obtained by
analyzing the EMG and acceleration signals measured during the isometric contraction and
elbow extension movements [28, 29]. In fact, it has been observed previously, that the elbow
extension movements are more impaired than the flexion movements of PD patients [33]. The
isometric approachwasmost sensitive to patients with associated tremor [28] and the dynamic
approach to patients with various motor symptoms (rigidity, bradykinesia and tremor) and
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Figure 12. The first PCs (θj(1)) and UPDRS -motor scores of nine PD patients with medication off, and
two and three and hour hours after taking the medication. The first eigenvector (bottom right).
especially to patients with problems in performing movement tasks [29]. Therefore, the
analysis of both kind of muscle contractions is essential when quantifying motor impairment
in PD.
5.2. Quantification of the effects of treatment
In studies [30, 31], we developed methods for quantifying the effects of treatment in PD on
the basis of surface EMG and kinematic measurements and analysis. The results of the study
[30] show that the measured EMG and acceleration signals of 12 out of 13 PD patients were
more similar with the signals of the healthy subjects with DBS on than with DBS off. This
result indicates that it is possible to detect DBS-induced improvements in the neuromuscular
and motor function of PD patients by using the developed analysis approach.
In [31], the EMG signals of eight out of nine PD patients changed into less spiky
and the acceleration recordings into more complex after taking the medication. A
reverse phenomenon in the signal characteristics was observed 3–4 hours after taking the
medication for seven out of nine patients. This result indicates that it is possible to detect
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medication-induced changes in the neuromuscular and motor function of PD patients by
using the developed methods.
5.3. Methods of signal analysis
We extracted a large number of features from the EMG and acceleration signals of PD patients
and healthy subjects in [28–32] and chose the most effective features for characterizing PD and
the effects of treatment into the feature vectors for deeper analysis. The chosen EMG features
were not conventional EMG parameters but they were based on nonlinear dynamics, signal
morphology, wavelets and EMG-acceleration coherence. Previously, there have been only one
[14] or few other studies, in which amethod of nonlinear dynamics has been used for studying
EMGs of PD patients. Our studies [30, 31] are the only studies that have analyzed the effects
of PD treatment (DBS and medication) by using methods of nonlinear dynamics for EMG.
All of the studies [28–32] were based on an innovative way of combining the PC-based
approachwith the selection of feature vectors instead of analyzing the statistics of single signal
parameters. The PC-based approach provided a better discrimination between the subjects by
capturing essential information in the combination of variables. With the PC-based approach,
it was possible to examine the effects of treatment in a feature space on an individual level.
Few things about signal quality and electrode placement should be kept in mind when
analyzing the EMG signals with the proposed analysis methods. First, the EMG signal
amplitude is relatively low and the signal is sensitive to noise that is coming from other
electrical sources. This noise may affect the calculated signal parameters. Therefore, the
noise should be eliminated already during themeasurements whenever it is possible. Another
thing is that sometimes a largeMU is firing constantly and dominantly in the proximity of the
recording electrode causing recurring impulse-like patterns into the EMG signal. In that case,
a better placement of recording electrodes would be advisable.
In PD patients with DBS, the stimulator causes artifacts into the EMG signal. The DBS artifact
and its filtering may affect the calculated signal parameters. Previously, the DBS artifact has
been removed from the EMG signal by low-pass filtering the rectified signal with a low (20–60
Hz) cut-off frequency [21, 41, 42, 51, 52]. In our study [30], we low-pass filtered the EMG
signal with the 110 Hz cut-off frequency. Our aim was to remove the DBS artifact from the
EMG as effectively as possible without removing important information and to perform the
filtering in the same way for all subjects in order to get comparable results.
5.4. Conclusions
In this chapter, we presented several approaches for feature extraction from surface EMG
and acceleration signals and for discrimination between PD patients and healthy subjects
on the basis of the extracted signal features. The presented discrimination approaches
were developed in our studies [28, 29, 32]. By using the developed approaches, we could
discriminate 72-80 % of PD patients from 82-90 % of healthy subjects depending on the
analyzed signal features and the muscle contraction type. These percentages can be regarded
as promising because it is known that the PD diagnostics can be difficult. Clinicopathological
studies from the UK and Canada have shown that the disease is diagnosed incorrectly in
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about 25 % of cases [48]. On the basis of our discrimination results, further research and
clinical studies are suggested for evaluating the sensitivity of the developed approaches in
patients with different types of PD and in patients with early stages of PD. In addition, the
ability of EMG and acceleration signal features in discriminating between PD patients and
other patients with similar symptoms should be studied.
In this chapter, we presented two approaches for quantifying the effects of PD treatment
(medication and DBS) on the basis of the extracted EMG and acceleration signal features.
The presented approaches were developed in our studies [30, 31]. By using the
developed approaches, we could detect DBS- and medication-induced improvements in the
neuromuscular and motor function of PD patients. This result is encouraging because the
widely used method for evaluating the efficacy of PD treatment is subjective. However, the
sensitivity of the developed approaches should be quantified with a larger number of PD
patients.
The need for finding objective methods for PD diagnosis and for quantifying the disease
progression and the efficacy of treatment is well known [2, 11, 24]. We hope that our results
[28–32] can help in creating a practical method for quantifying motor impairment in PD and
the effects of treatment on individual PD patients. However, in order to be more sensitive
than the traditional methods, it is probable that a combination of several objective methods
will be needed for PD.
5.5. Future directions
There is currently a lot of effort for determining objective methods and characteristics for PD
[2, 11, 24]. One important goal of current research is to determine criteria for the pre-motor
and pre-clinical phases of PD [39]. In surface EMG studies, the sensitivity of surface EMG
signal features in detecting PD patients before the actual diagnosis of PD should be studied.
It will be important to analyze differences in the signal characteristics between PD patients
and other patients with similar symptoms. These other similar diseases form currently a
significant reason for the wrong diagnosis of PD [17]. It has been observed that surface
EMGand kinematicmeasurements can provide information about the effects of PD treatments
(medication and DBS). The ability of these measurements in helping the optimal adjustment
of these treatments should be evaluated.
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